• Lonnie Granier

ONDCP: Elimination of X-Waiver Requirement Announced Prematurely

Office of National Drug Control Policy: "On January 14, 2021, HHS announced forthcoming Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder. Unfortunately, the announcement was made prematurely. Therefore, the Guidelines previously announced cannot be issued at this time. However, HHS and ONDCP are committed to working with interagency partners to examine ways to increase access to buprenorphine, reduce overdose rates and save lives."

3 views0 comments

Recent Posts

See All

New report released on repealing the IMD Exclusion

A new report entitled Medicaid's IMD Exclusion: The Case for Repeal makes the case that the decades-old federal law that prohibits specialty psychiatric facilities from billing Medicaid served its pu

Subscribe to Our Newsletter

© 2020 by CLASPP